ENTITY

Dynavax Technologies (DVAX US)

4
Analysis
Health CareUnited States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Company Event13 Dec 2025 03:10 • Upcoming
Add To Calendar
Company Event20 Feb 2026 05:30 • Upcoming
Add To Calendar
Company Event06 Nov 2025 05:30 • Latest
Company Event08 Aug 2025 04:30
Company Event11 Jun 2025 22:00 • Upcoming
Add To Calendar
x